Losavio, Francesco Antonio
 Distribuzione geografica
Continente #
NA - Nord America 227
EU - Europa 166
AS - Asia 97
SA - Sud America 21
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 517
Nazione #
US - Stati Uniti d'America 226
SE - Svezia 69
CN - Cina 44
DE - Germania 29
FR - Francia 28
SG - Singapore 27
BR - Brasile 18
IE - Irlanda 10
GB - Regno Unito 9
IN - India 9
ID - Indonesia 7
FI - Finlandia 6
RU - Federazione Russa 6
CI - Costa d'Avorio 3
HK - Hong Kong 3
UA - Ucraina 3
RO - Romania 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
CL - Cile 1
EU - Europa 1
IQ - Iraq 1
IT - Italia 1
JP - Giappone 1
KH - Cambogia 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 517
Città #
Chandler 85
Beijing 23
Singapore 18
Wilmington 12
Ashburn 11
Dublin 10
Los Angeles 8
Jakarta 7
Marseille 7
Princeton 7
San Mateo 7
Boston 6
Helsinki 6
New York 5
Abidjan 3
Düsseldorf 3
Falls Church 3
Frankfurt am Main 3
Hong Kong 3
Jacksonville 3
Leawood 3
Moscow 3
Nanchang 3
Nuremberg 3
Portsmouth 3
Bremen 2
Brooklyn 2
Buffalo 2
Fairfield 2
Hyderabad 2
Lviv 2
Munich 2
Nanjing 2
Recife 2
Redwood City 2
São Paulo 2
Alegrete 1
Andover 1
Ann Arbor 1
Anápolis 1
Aracaju 1
Atlanta 1
Baku 1
Bangalore 1
Belo Jardim 1
Bexley 1
Blumenau 1
Brussels 1
Cachoeira Paulista 1
Cachoeiro de Itapemirim 1
Caxias do Sul 1
Chicago 1
Eden Prairie 1
Edinburgh 1
Falkenstein 1
Forest City 1
Franca 1
Gravatá do Ibiapina 1
Hebei 1
Helena 1
Ho Chi Minh City 1
Houston 1
Ipanema 1
Kathmandu 1
Kemerovo 1
La Paz 1
La Plata 1
Lauterbourg 1
London 1
Mandaguaçu 1
Mosul 1
Mumbai 1
Nürnberg 1
Patrocínio 1
Phnom Penh 1
Praia Grande 1
Pune 1
Rabat 1
Rome 1
Roubaix 1
Sacramento 1
San Francisco 1
Sydney 1
Wuhan 1
Yerevan 1
Totale 316
Nome #
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 98
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 81
Posterior reversible encephalopathy syndrome after intramuscular oxygen-ozone therapy 73
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 71
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 70
A unique case of multiphasic ADEM or what else? 68
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 66
Totale 527
Categoria #
all - tutte 2.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202132 3 2 1 2 0 1 4 2 0 2 11 4
2021/202285 10 0 0 12 1 5 0 14 5 4 13 21
2022/2023188 26 30 15 28 7 21 15 15 22 0 8 1
2023/202453 2 15 0 2 0 5 6 0 1 1 7 14
2024/2025121 2 5 8 12 5 12 4 9 12 23 29 0
Totale 527